Opendata, web and dolomites

SOLID SIGNED

Suppression of Organelle Defects in Human Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SOLID project word cloud

Explore the words cloud of the SOLID project. It provides you a very rough idea of what is the project "SOLID" about.

platform    time    extensive    hurdles    recessive    metabolic    stratification    suppressor    cell    cures    organelle    correct    disorders    organelles    diseases    alter    exemplified    perturbed    captures    uncover    function    hidden    eukaryotic    fashion    organisms    haploid    cellular    query    causative    engineering    mutations    mitochondria    lacking    fixed    surveys    create    strategies    incurable    paradigm    instead    departs    centric    independent    diversity    revealing    phenotypes    disease    view    mainly    etiological    human    biology    yeast    direct    remove    mostly    alongside    mapping    biological    suppression    machines    gene    until    relies    drugging    interrogate    systematic    defects    impaired    frustrations    exhaustive    initial    contain    entirely    questions    fidelity    therapeutic    altogether    modules    urgently    point    ultradeep    solid    triggers    groundbreaking    mutants    limited    possibilities    malfunctioning    lysosomes    concerted    substantial    genetics    hundreds    absent    mutagenesis    yielding    genome    environmental    genetic    neurodegeneration    genes    suppressors    mutation    functioning    model    reveal    combines    uniquely    fitness    perturbation    first    applicable    amount    difficulty   

Project "SOLID" data sheet

The following table provides information about the project.

Coordinator
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN 

Organization address
address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539
website: www.uni-muenchen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙498˙400 €
 EC max contribution 1˙498˙400 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2024-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) coordinator 1˙498˙400.00

Map

 Project objective

The goal of SOLID is the systematic mapping of genetic suppression for important organelles with impaired fidelity in human disease to uncover new strategies to correct the perturbed state. Functioning of the eukaryotic cell relies on the concerted activity of biological machines, defects in which can cause incurable human disease, including metabolic disorders and neurodegeneration. This is exemplified by malfunctioning mitochondria or lysosomes, for which (alongside environmental triggers) hundreds of causative genes have been identified, but cures are mostly lacking. This is mainly due to the difficulty of drugging loss-of-function mutations, which uniquely alter or entirely remove the gene product. Extensive studies in yeast and initial work in the human system show that cellular modules contain a substantial amount of hidden genetic suppression. Revealing suppressors of disease-defining features of organelle perturbation and targeting those instead of the query mutations, will address the frustrations of drugging an absent factor and etiological diversity. Until now, mutation-based genome-wide suppressor surveys were mostly limited to model organisms and phenotypes yielding growth defects, due to technical hurdles associated with recessive genetics in the human system. However, with the development of a groundbreaking new forward genetics platform that combines genome engineering, ultradeep haploid mutagenesis and direct stratification of fixed mutants, we can now, for the first time, interrogate genetic suppression of human organelle defects independent of cellular fitness. SOLID will also develop new technology to study organelle fidelity in an exhaustive fashion that departs from a gene-centric view point and captures complex phenotypes. Altogether, this will create a new paradigm of 'studying cell biology via genetics' widely applicable to many different biological questions, and reveal urgently needed novel therapeutic possibilities for incurable diseases.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SOLID" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SOLID" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

AST (2019)

Automatic System Testing

Read More  

CURVE-X (2019)

Industrialisation of curved sensors and related imagers

Read More  

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More